HARVARD BIOSCIENCE, INC. Revenues
HARVARD BIOSCIENCE, INC. (HBIO) reported Revenues of $23.77 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-08.
Discontinued › Income Statement
us-gaap:Revenues · last filed 2020-05-08
- HARVARD BIOSCIENCE, INC. revenues for the quarter ending 2020-03-31 was $23.77M, a 15.71% decline year-over-year.
- HARVARD BIOSCIENCE, INC. revenues for the quarter ending 2019-12-31 was $30.97M, a 8.52% decline year-over-year.
- HARVARD BIOSCIENCE, INC. revenues for the quarter ending 2019-09-30 was $27.42M, a 4.25% decline year-over-year.
- HARVARD BIOSCIENCE, INC. revenues for the quarter ending 2019-06-30 was $29.58M, a 6.15% decline year-over-year.
- HARVARD BIOSCIENCE, INC. revenues for fiscal 2019 was $116.18M, a 3.81% decline from fiscal 2018.
- HARVARD BIOSCIENCE, INC. revenues for fiscal 2018 was $120.77M, a 56.02% increase from fiscal 2017.
- HARVARD BIOSCIENCE, INC. revenues for fiscal 2017 was $77.41M, a 25.94% decline from fiscal 2016.
- HARVARD BIOSCIENCE, INC. revenues for fiscal 2016 was $104.52M, a 3.81% decline from fiscal 2015.
| Period end | Revenues 3 month | Revenues 3 month as first filed | Revenues 6 month | Revenues 6 month as first filed | Revenues 9 month | Revenues 9 month as first filed | Revenues 12 month | Revenues 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2020-03-31 | $23.77M 10-Q · filed 2020-05-08 | $54.74M derived: sum of 2 quarters · filed 2020-05-08 | $82.16M derived: sum of 3 quarters · filed 2020-05-08 | $111.75M derived: sum of 4 quarters · filed 2020-05-08 | ||||
| 2019-12-31 | $30.97M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $58.39M derived: sum of 2 quarters · filed 2020-03-16 | $87.97M derived: sum of 3 quarters · filed 2020-03-16 | $116.18M 10-K · filed 2020-03-16 | ||||
| 2019-09-30 | $27.42M 10-Q · filed 2019-11-08 | $57.00M derived: sum of 2 quarters · filed 2019-11-08 | $85.20M 10-Q · filed 2019-11-08 | $119.06M derived: sum of 4 quarters · filed 2020-05-08 | ||||
| 2019-06-30 | $29.58M 10-Q · filed 2019-08-08 | $57.79M 10-Q · filed 2019-08-08 | $91.64M derived: sum of 3 quarters · filed 2020-05-08 | $120.28M derived: sum of 4 quarters · filed 2020-05-08 | ||||
| 2019-03-31 | $28.20M 10-Q · filed 2020-05-08 | $62.06M derived: sum of 2 quarters · filed 2020-05-08 | $90.69M derived: sum of 3 quarters · filed 2020-05-08 | $122.22M derived: sum of 4 quarters · filed 2020-05-08 | ||||
| 2018-12-31 | $33.86M 10-K · filed 2019-03-18 | $62.49M derived: sum of 2 quarters · filed 2019-11-08 | $94.02M derived: sum of 3 quarters · filed 2019-11-08 | $120.77M 10-K · filed 2020-03-16 | ||||
| 2018-09-30 | $28.64M 10-Q · filed 2019-11-08 | $60.16M derived: sum of 2 quarters · filed 2019-11-08 | $86.92M 10-Q · filed 2019-11-08 | $108.56M derived: sum of 4 quarters · filed 2019-11-08 | ||||
| 2018-06-30 | $31.52M 10-Q · filed 2019-08-08 | $58.28M 10-Q · filed 2019-08-08 | $79.93M derived: sum of 3 quarters · filed 2019-08-08 | $98.64M derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | $26.76M 10-Q · filed 2019-05-08 | $48.41M derived: sum of 2 quarters · filed 2019-05-08 | $67.12M derived: sum of 3 quarters · filed 2019-05-08 | $86.08M derived: sum of 4 quarters · filed 2019-05-08 | ||||
| 2017-12-31 | $21.65M 10-K · filed 2019-03-18 | $27.46M 10-K · filed 2018-03-16 | $40.36M derived: sum of 2 quarters · filed 2019-03-18 | $59.32M derived: sum of 3 quarters · filed 2019-03-18 | $77.41M 10-K · filed 2019-03-18 | $101.88M 10-K · filed 2018-03-16 | ||
| 2017-09-30 | $18.72M 10-K · filed 2019-03-18 | $25.05M 10-Q · filed 2017-11-02 | $37.67M derived: sum of 2 quarters · filed 2019-03-18 | $55.76M 10-Q · filed 2018-11-01 | $74.42M 10-Q · filed 2017-11-02 | $82.18M derived: sum of 4 quarters · filed 2019-03-18 | ||
| 2017-06-30 | $18.96M 10-K · filed 2019-03-18 | $25.21M 10-Q · filed 2017-08-03 | $37.04M 10-Q · filed 2018-08-02 | $49.37M 10-Q · filed 2017-08-03 | $63.46M derived: sum of 3 quarters · filed 2019-03-18 | $88.47M derived: sum of 4 quarters · filed 2019-03-18 | ||
| 2017-03-31 | $18.09M 10-K · filed 2019-03-18 | $24.16M 10-Q · filed 2017-05-08 | $44.50M derived: sum of 2 quarters · filed 2019-03-18 | $69.51M derived: sum of 3 quarters · filed 2019-03-18 | $95.64M derived: sum of 4 quarters · filed 2019-03-18 | |||
| 2016-12-31 | $26.41M 10-K · filed 2018-03-16 | $51.42M derived: sum of 2 quarters · filed 2018-03-16 | $77.56M derived: sum of 3 quarters · filed 2018-03-16 | $104.52M 10-K · filed 2018-03-16 | ||||
| 2016-09-30 | $25.01M 10-K · filed 2018-03-16 | $51.14M derived: sum of 2 quarters · filed 2018-03-16 | $78.11M 10-Q · filed 2017-11-02 | $106.48M derived: sum of 4 quarters · filed 2018-03-16 | ||||
| 2016-06-30 | $26.14M 10-K · filed 2018-03-16 | $53.10M 10-Q · filed 2017-08-03 | $81.47M derived: sum of 3 quarters · filed 2018-03-16 | $107.20M derived: sum of 4 quarters · filed 2018-03-16 | ||||
| 2016-03-31 | $26.96M 10-K · filed 2018-03-16 | $55.33M derived: sum of 2 quarters · filed 2018-03-16 | $81.06M derived: sum of 3 quarters · filed 2018-03-16 | $109.86M derived: sum of 4 quarters · filed 2018-03-16 | ||||
| 2015-12-31 | $28.37M 10-K · filed 2017-03-17 | $54.10M derived: sum of 2 quarters · filed 2017-03-17 | $82.90M derived: sum of 3 quarters · filed 2017-03-17 | $108.66M 10-K · filed 2018-03-16 | ||||
| 2015-09-30 | $25.73M 10-K · filed 2017-03-17 | $54.53M derived: sum of 2 quarters · filed 2017-03-17 | $80.29M 10-Q · filed 2016-11-03 | $110.66M derived: sum of 4 quarters · filed 2017-03-17 | ||||
| 2015-06-30 | $28.80M 10-K · filed 2017-03-17 | $54.56M 10-Q · filed 2016-08-04 | $84.93M derived: sum of 3 quarters · filed 2017-03-17 | $110.38M derived: sum of 4 quarters · filed 2017-03-17 | ||||
| 2015-03-31 | $25.76M 10-K · filed 2017-03-17 | $56.13M derived: sum of 2 quarters · filed 2017-03-17 | $81.58M derived: sum of 3 quarters · filed 2017-03-17 | $108.53M derived: sum of 4 quarters · filed 2017-03-17 | ||||
| 2014-12-31 | $30.36M 10-K · filed 2016-04-29 | $55.81M derived: sum of 2 quarters · filed 2016-04-29 | $82.77M derived: sum of 3 quarters · filed 2016-04-29 | $108.66M 10-K · filed 2017-03-17 | ||||
| 2014-09-30 | $25.45M 10-K · filed 2016-04-29 | $52.41M derived: sum of 2 quarters · filed 2016-04-29 | $78.30M 10-Q · filed 2015-11-05 | $106.15M derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2014-06-30 | $26.96M 10-K · filed 2016-04-29 | $52.85M 10-Q · filed 2015-08-06 | $80.70M derived: sum of 3 quarters · filed 2016-04-29 | $105.84M derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2014-03-31 | $25.89M 10-K · filed 2016-04-29 | $53.75M derived: sum of 2 quarters · filed 2016-04-29 | $78.88M derived: sum of 3 quarters · filed 2016-04-29 | $104.98M derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2013-12-31 | $27.85M 10-K · filed 2015-03-12 | $52.99M derived: sum of 2 quarters · filed 2015-03-12 | $79.08M derived: sum of 3 quarters · filed 2015-03-12 | $105.17M 10-K · filed 2016-04-29 | ||||
| 2013-09-30 | $25.14M 10-K · filed 2015-03-12 | $51.23M derived: sum of 2 quarters · filed 2015-03-12 | $77.32M 10-Q · filed 2014-11-06 | $105.57M derived: sum of 4 quarters · filed 2015-03-12 | ||||
| 2013-06-30 | $26.09M 10-K · filed 2015-03-12 | $52.18M 10-Q · filed 2014-08-07 | $80.43M derived: sum of 3 quarters · filed 2015-03-12 | $106.53M derived: sum of 4 quarters · filed 2015-03-12 | ||||
| 2013-03-31 | $26.09M 10-K · filed 2015-03-12 | $54.34M derived: sum of 2 quarters · filed 2015-03-12 | $80.44M derived: sum of 3 quarters · filed 2015-03-12 | $108.94M derived: sum of 4 quarters · filed 2015-03-12 | ||||
| 2012-12-31 | $28.25M 10-K · filed 2014-03-14 | $54.35M derived: sum of 2 quarters · filed 2014-03-14 | $82.85M derived: sum of 3 quarters · filed 2014-03-14 | $111.17M 10-K · filed 2015-03-12 | ||||
| 2012-09-30 | $26.10M 10-K · filed 2014-03-14 | $54.60M derived: sum of 2 quarters · filed 2014-03-14 | $82.92M 10-Q · filed 2013-11-08 | $111.95M derived: sum of 4 quarters · filed 2014-03-14 | ||||
| 2012-06-30 | $28.50M 10-K · filed 2014-03-14 | $56.82M 10-Q · filed 2013-08-09 | $85.85M derived: sum of 3 quarters · filed 2014-03-14 | $112.23M derived: sum of 4 quarters · filed 2014-03-14 | ||||
| 2012-03-31 | $28.32M 10-K · filed 2014-03-14 | $57.35M derived: sum of 2 quarters · filed 2014-03-14 | $83.73M derived: sum of 3 quarters · filed 2014-03-14 | $110.87M derived: sum of 4 quarters · filed 2014-03-14 | ||||
| 2011-12-31 | $29.03M 10-K · filed 2013-03-18 | $55.41M derived: sum of 2 quarters · filed 2013-03-18 | $82.55M derived: sum of 3 quarters · filed 2013-03-18 | $108.86M 10-K · filed 2014-03-14 | ||||
| 2011-09-30 | $26.38M 10-K · filed 2013-03-18 | $53.52M derived: sum of 2 quarters · filed 2013-03-18 | $79.84M 10-Q · filed 2012-11-08 | $109.36M derived: sum of 4 quarters · filed 2013-03-18 | ||||
| 2011-06-30 | $27.14M 10-K · filed 2013-03-18 | $53.46M 10-Q · filed 2012-08-09 | $82.98M derived: sum of 3 quarters · filed 2013-03-18 | $109.43M derived: sum of 4 quarters · filed 2013-03-18 | ||||
| 2011-03-31 | $26.31M 10-K · filed 2013-03-18 | $55.83M derived: sum of 2 quarters · filed 2013-03-18 | $82.29M derived: sum of 3 quarters · filed 2013-03-18 | $108.19M derived: sum of 4 quarters · filed 2013-03-18 | ||||
| 2010-12-31 | $29.52M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $55.97M derived: sum of 2 quarters · filed 2013-03-18 | $81.88M derived: sum of 3 quarters · filed 2013-03-18 | $108.18M 10-K · filed 2013-03-18 | ||||
| 2010-09-30 | $26.45M 10-Q · filed 2011-11-09 | $52.36M derived: sum of 2 quarters · filed 2011-11-09 | $78.66M 10-Q · filed 2011-11-09 | |||||
| 2010-06-30 | $25.91M 10-Q · filed 2011-08-09 | $52.20M 10-Q · filed 2011-08-09 | ||||||
| 2009-12-31 | $85.77M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |